Related Experiment Video
Updated: Mar 20, 2026
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
Published on: August 23, 2016
First Case of Zika Virus Infection in a HIV+ Patient
1Tropical & Travel Medicine Unit, Hospital Carlos III-La Paz, Madrid, Spain.
Abstract:
Zika virus is an enveloped, single-stranded RNA virus that belongs to the flavivirus genre. As with arbovirus, it is transmitted by arthropods (mosquitoes), both Aedes aegypti (urban) and albopictus (rural). Zika virus was first isolated in 1947 from monkeys in Uganda. The first human cases were reported in 1952 in East Africa. Outbreaks were reported in Micronesia (2007), Polynesia (2013), and Chile (2014). Both diagnostic procedures and therapeutics are poorly developed. Serological tests cross-react with dengue and there are neither specific antivirals nor vaccines.
Insights
Zika virus, a flavivirus transmitted by mosquitoes, poses a global health threat. Current diagnostics and treatments are limited, highlighting an urgent need for better medical interventions.
Area of Science:
- Virology
- Arthropod-borne viruses
Background:
- Zika virus is an enveloped, single-stranded RNA virus within the Flaviviridae family.
- It is transmitted by arthropods, primarily mosquitoes of the Aedes genus.
Observation:
- First isolated in Uganda in 1947 from monkeys.
- First human cases documented in East Africa in 1952.
- Significant outbreaks occurred in Micronesia (2007), Polynesia (2013), and Chile (2014).
Findings:
- Diagnostic methods for Zika virus are underdeveloped.
- Serological tests exhibit cross-reactivity with dengue virus.
- No specific antiviral treatments or vaccines are currently available.
Implications:
- The lack of effective diagnostics and therapeutics presents a major challenge for controlling Zika virus outbreaks.
- Further research is critical for developing targeted antivirals and vaccines.
- Enhanced surveillance and diagnostic capabilities are needed globally.
